Luciferase-labelled Luciferase NCI-H929 Cell Line, capable of developing tumors in vivo, can be used for studying the efficacy of anti-tumor drugs. For cells with unconfirmed tumorigenic effects, Genomeditech provides three different monoclonal cells for customers to select and validate independently. Additionally, each cell has been analyzed for Luciferase luminescence signal intensity.